Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.
Hiroshi HasegawaTakeru MatsudaKimihiro YamashitaRyuichiro SawadaHitoshi HaradaNaoki UrakawaHironobu GotoShingo KanajiTaro OshikiriYoshihiro KakejiPublished in: Langenbeck's archives of surgery (2022)
In patients with rectal or anal canal adenocarcinoma associated with clinical ILNM, radical resection with neoadjuvant therapy provides a good long-term survival.